Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
e decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
e decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
37981
Table 1_Emergency department utilization among youth in foster care: benefits of a patient-centered medical home.pdf
Published 2025“…The patient-centered medical home (PCMH) offers a potential model to reduce overutilization of healthcare resources. …”
-
37982
-
37983
-
37984
-
37985
Expression levels of <i>th1</i> and <i>th2</i> mRNA at 3 dpf in <i>pink1</i> morphants untreated and treated with LGR.
Published 2013“…A decrease in <i>th1</i> expression in the population 5,6,11 (*) in morphants (B) was observed as compared to the ctrl MO group (A). …”
-
37986
Unidirectional Drug Delivery and Responsive Release Guided by Nanofunnel-Shaped Heterojunction
Published 2025“…The potential of mean force calculations reveal energy barriers scale as Δ<i>G</i> ∝ 1/<i>R</i><sup>2</sup>, with BN nanotubes showing 20–30% higher barriers (e.g., −19.63 vs −14.14 kcal·mol<sup>–1</sup> for graphene) due to stronger van der Waals interactions. …”
-
37987
Unidirectional Drug Delivery and Responsive Release Guided by Nanofunnel-Shaped Heterojunction
Published 2025“…The potential of mean force calculations reveal energy barriers scale as Δ<i>G</i> ∝ 1/<i>R</i><sup>2</sup>, with BN nanotubes showing 20–30% higher barriers (e.g., −19.63 vs −14.14 kcal·mol<sup>–1</sup> for graphene) due to stronger van der Waals interactions. …”
-
37988
Unidirectional Drug Delivery and Responsive Release Guided by Nanofunnel-Shaped Heterojunction
Published 2025“…The potential of mean force calculations reveal energy barriers scale as Δ<i>G</i> ∝ 1/<i>R</i><sup>2</sup>, with BN nanotubes showing 20–30% higher barriers (e.g., −19.63 vs −14.14 kcal·mol<sup>–1</sup> for graphene) due to stronger van der Waals interactions. …”
-
37989
Unidirectional Drug Delivery and Responsive Release Guided by Nanofunnel-Shaped Heterojunction
Published 2025“…The potential of mean force calculations reveal energy barriers scale as Δ<i>G</i> ∝ 1/<i>R</i><sup>2</sup>, with BN nanotubes showing 20–30% higher barriers (e.g., −19.63 vs −14.14 kcal·mol<sup>–1</sup> for graphene) due to stronger van der Waals interactions. …”
-
37990
Unidirectional Drug Delivery and Responsive Release Guided by Nanofunnel-Shaped Heterojunction
Published 2025“…The potential of mean force calculations reveal energy barriers scale as Δ<i>G</i> ∝ 1/<i>R</i><sup>2</sup>, with BN nanotubes showing 20–30% higher barriers (e.g., −19.63 vs −14.14 kcal·mol<sup>–1</sup> for graphene) due to stronger van der Waals interactions. …”
-
37991
-
37992
Detailed Analysis of Sequence Changes Occurring during <em>vlsE</em> Antigenic Variation in the Mouse Model of <em>Borrelia burgdorferi</em> Infection
Published 2009“…Sequence changes as small as one base pair were common. Fifteen percent of recovered <em>vlsE</em> variants contained “template-independent” sequence changes, which clustered in the variable regions of <em>vlsE</em>. …”
-
37993
-
37994
Table_3_Derivation of Breast Cancer Cell Lines Under Physiological (5%) Oxygen Concentrations.DOCX
Published 2018“…We have derived and grown a series of four human breast cancer cell lines under 5% oxygen, and have compared their properties to those of established breast cancer lines growing under ambient oxygen.…”
-
37995
Table_2_Derivation of Breast Cancer Cell Lines Under Physiological (5%) Oxygen Concentrations.DOCX
Published 2018“…We have derived and grown a series of four human breast cancer cell lines under 5% oxygen, and have compared their properties to those of established breast cancer lines growing under ambient oxygen.…”
-
37996
-
37997
-
37998
-
37999
Table_1_Safety and efficacy of lecanemab for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials.DOCX
Published 2023“…It is reported that lecanemab was beneficial to stabilize or slow down the decrease in CDR-SB (WMD: −0.45; 95% CI: −0.64, −0.25; p < 0.00001), ADCOMS (WMD: −0.05; 95% CI: −0.07, −0.03; p < 0.00001), ADAS-cog (WMD: −1.11; 95% CI: −1.64, −0.57; p < 0.0001), amyloid PET SUVr (WMD: −0.15; 95% CI: −0.48, 0.19; p = 0.38), amyloid burden on PET (WMD:−35.44; 95% CI: −65.22,−5.67; p = 0.02), adverse events (subjects with any TEAE) (OR: 0.73; 95% CI: 0.25, 2.15; p = 0.57), ARIA-E (OR:8.95; 95% CI: 5.36, 14.95; p < 0.00001), and ARIA-H (OR:2.00; 95% CI: 1.53, 2.62; p < 0.00001) in early AD patients.…”
-
38000